Boosting muscle lymphatics to help Duchenne muscular dystrophy
Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation
Researchers are trying to grow more lymphatic vessels in muscle to lower inflammation and help people with Duchenne muscular dystrophy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11308326 on NIH RePORTER |
What this research studies
This project uses lab models of Duchenne muscular dystrophy to study how the lymphatic system in muscle affects inflammation and weakness. Scientists increase a lymphatic growth protein called VEGF-D in muscle and measure whether that makes more lymphatic vessels and improves lymph flow. They look at muscle size, strength, and inflammatory markers in affected muscles to see if the changes help. Findings could guide new treatments that target muscle lymphatics to protect or repair muscle in DMD.
Who could benefit from this research
Good fit: People living with Duchenne muscular dystrophy, particularly those with evidence of ongoing muscle inflammation, would be the most relevant candidates for related future clinical trials.
Not a fit: People without Duchenne muscular dystrophy or those with very advanced, irreversible muscle or organ damage may not benefit from this lymphatic-targeted approach.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce muscle inflammation and slow muscle loss in people with Duchenne muscular dystrophy.
How similar studies have performed: Early animal data show that boosting lymphatic growth can increase vessel density and sometimes improve muscle weight and strength, but translating this approach to people is still new and unproven.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Muthuchamy, Mariappan — Texas A&m University Health Science Ctr
- Study coordinator: Muthuchamy, Mariappan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.